Back to Search
Start Over
Survival in France after childhood acute leukaemia and non-Hodgkin's lymphoma (1990-2000)
- Source :
- European Journal of Cancer, European Journal of Cancer, 2006, 42 (4), pp.534-41. ⟨10.1016/j.ejca.2005.08.041⟩, European Journal of Cancer, Elsevier, 2006, 42 (4), pp.534-41. ⟨10.1016/j.ejca.2005.08.041⟩
- Publication Year :
- 2006
- Publisher :
- HAL CCSD, 2006.
-
Abstract
- International audience; This article describes the survival after childhood acute leukaemia (AL) and non-Hodgkin's lymphoma (NHL) of French population aged less than 15 years. The French National Registry of Childhood Leukaemia and Lymphoma recorded 3995 cases of acute lymphoblastic leukaemia (ALL), 812 of acute myeloid leukaemia (AML) and 1137 of NHL over the period from 1990 to 2000. Overall survival rates at 5 years were 82% (95% CI 80-83), 58% (95% CI 54-61) and 87% (95% CI 85-89) for ALL, AML and NHL, respectively. Survival after AL increased from 77% (95% CI 75-80) in 1990-1992 to 85% (95% CI 83-87) in 1997-2000 for ALL and from 47% (95% CI 41-54) to 61% (95% CI 55-67) for AML. Among AL cases, children aged 1-4 years had the most favourable prognosis. Down's syndrome was associated with poor survival after ALL. No gender-related variations in survival were in evidence. The results reported herein are similar to those reported by other European registries and clinical trials.
- Subjects :
- Male
Cancer Research
Pediatrics
0302 clinical medicine
MESH: Lymphoma, Non-Hodgkin
hemic and lymphatic diseases
MESH: Child
030212 general & internal medicine
Child
education.field_of_study
Acute leukemia
Clinical Trials as Topic
Lymphoma, Non-Hodgkin
MESH: Clinical Trials
MESH: Infant, Newborn
Precursor Cell Lymphoblastic Leukemia-Lymphoma
MESH: Infant
3. Good health
Childhood leukaemia
Survival Rate
MESH: Leukemia, Lymphocytic, Acute, L1
Oncology
030220 oncology & carcinogenesis
Child, Preschool
Female
France
medicine.medical_specialty
Adolescent
MESH: Survival Rate
MESH: Clinical Trials as Topic
Population
Antineoplastic Agents
03 medical and health sciences
medicine
Humans
education
Survival rate
MESH: Adolescent
MESH: Precursor Cell Lymphoblastic Leukemia-Lymphoma
MESH: Humans
business.industry
MESH: Child, Preschool
Infant, Newborn
Infant
MESH: Down Syndrome
medicine.disease
MESH: Male
Lymphoma
Non-Hodgkin's lymphoma
Clinical trial
MESH: France
El Niño
[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie
MESH: Antineoplastic Agents
[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie
Down Syndrome
business
MESH: Female
Subjects
Details
- Language :
- English
- ISSN :
- 19901992 and 09598049
- Database :
- OpenAIRE
- Journal :
- European Journal of Cancer, European Journal of Cancer, 2006, 42 (4), pp.534-41. ⟨10.1016/j.ejca.2005.08.041⟩, European Journal of Cancer, Elsevier, 2006, 42 (4), pp.534-41. ⟨10.1016/j.ejca.2005.08.041⟩
- Accession number :
- edsair.doi.dedup.....8b16781d11949783f9f448b7e594194d
- Full Text :
- https://doi.org/10.1016/j.ejca.2005.08.041⟩